Although Ozempic and other weight-loss drugs may seem like a relatively new phenomenon, their origins actually stretch back to the mid 1980s. Back then, scientists were searching for an alternative treatment for diabetes, one that could replace insulin. Few could have imagined that this research would go on to reshape the treatment of obesity and later evolve into one of the best-selling drugs in the world.In her new book Off the Scales, journalist and author Aimee Donnellan traces the history of Ozempic, telling the story of the people behind its development. Among them is a young, ambitious woman from Macedonia whose research helped pave the way for the creation of the drug. In today’s episode, Donnellan talks to Róisín Ingle about the seismic impact GLP-1s have had on society and the body positivity movement. But first, Irish Times opinion editor Jennifer O’Connell is here to discuss some of the biggest stories of the week including the Beckham family feud and one woman’s fourteen-year-fight to get her former partner prosecuted for domestic violence. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.